164 related articles for article (PubMed ID: 30952619)
41. LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
Ramirez-Ardila DE; Ruigrok-Ritstier K; Helmijr JC; Look MP; van Laere S; Dirix L; Berns EM; Jansen MP
Mol Oncol; 2016 Oct; 10(8):1363-73. PubMed ID: 27491861
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients.
Deng L; Zhu X; Sun Y; Wang J; Zhong X; Li J; Hu M; Zheng H
Cancer Res Treat; 2019 Jan; 51(1):128-140. PubMed ID: 29540052
[TBL] [Abstract][Full Text] [Related]
43. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
44. TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
Kuno I; Takayanagi D; Asami Y; Murakami N; Matsuda M; Shimada Y; Hirose S; Kato MK; Komatsu M; Hamamoto R; Okuma K; Kohno T; Itami J; Yoshida H; Shiraishi K; Kato T
Sci Rep; 2021 Sep; 11(1):19261. PubMed ID: 34584128
[TBL] [Abstract][Full Text] [Related]
45. Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.
Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Gandhi G; Rizvi MMA
Tumour Biol; 2017 Jun; 39(6):1010428317703635. PubMed ID: 28631565
[TBL] [Abstract][Full Text] [Related]
46. Identification of actionable mutations in malignant pleural mesothelioma.
Shukuya T; Serizawa M; Watanabe M; Akamatsu H; Abe M; Imai H; Tokito T; Ono A; Taira T; Kenmotsu H; Naito T; Murakami H; Takahashi T; Endo M; Ohde Y; Nakajima T; Yamamoto N; Koh Y
Lung Cancer; 2014 Oct; 86(1):35-40. PubMed ID: 25174276
[TBL] [Abstract][Full Text] [Related]
47. Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience.
Espenel S; Garcia MA; Langrand-Escure J; Vallard A; Trone JC; Rancoule C; Vial N; Moreno-Acosta P; Chauleur C; Boutet C; Peoc Apos H M; Prevot-Bitot N; Guy JB; Magné N
Oncology; 2019; 97(3):125-134. PubMed ID: 31266037
[TBL] [Abstract][Full Text] [Related]
48. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
49. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
[TBL] [Abstract][Full Text] [Related]
51. Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy.
Watanabe T; Nanamiya H; Kojima M; Nomura S; Furukawa S; Soeda S; Tanaka D; Isogai T; Imai JI; Watanabe S; Fujimori K
Sci Rep; 2020 Oct; 10(1):18734. PubMed ID: 33127935
[TBL] [Abstract][Full Text] [Related]
52. Identification of autosomal cis expression quantitative trait methylation (cis eQTMs) in children's blood.
Ruiz-Arenas C; Hernandez-Ferrer C; Vives-Usano M; Marí S; Quintela I; Mason D; Cadiou S; Casas M; Andrusaityte S; Gutzkow KB; Vafeiadi M; Wright J; Lepeule J; Grazuleviciene R; Chatzi L; Carracedo Á; Estivill X; Marti E; Escaramís G; Vrijheid M; González JR; Bustamante M
Elife; 2022 Mar; 11():. PubMed ID: 35302492
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
[TBL] [Abstract][Full Text] [Related]
54. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
55. Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.
Resteghini C; Perrone F; Miceli R; Bergamini C; Alfieri S; Orlandi E; Guzzo M; Granata R; Galbiati D; Cavalieri S; Locati L; Licitra L; Bossi P
Tumori; 2018 Jun; 104(3):213-220. PubMed ID: 29714670
[TBL] [Abstract][Full Text] [Related]
56. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract][Full Text] [Related]
57. Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859].
Park JH; Ahn JH; Kim JE; Jung KH; Gong G; Lee HJ; Son BH; Ahn SH; Kim HH; Shin HJ; Moon DH; Kim D; Kim SB
Anticancer Res; 2020 Oct; 40(10):5883-5893. PubMed ID: 32988919
[TBL] [Abstract][Full Text] [Related]
58. PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Jacot W; Dalenc F; Lopez-Crapez E; Chaltiel L; Durigova A; Gros N; Lozano N; Lacaze JL; Pouderoux S; Gladieff L; Romieu G; Roché H; Filleron T; Lamy PJ
Breast Cancer Res Treat; 2019 Oct; 177(3):659-667. PubMed ID: 31297647
[TBL] [Abstract][Full Text] [Related]
59. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
[TBL] [Abstract][Full Text] [Related]
60. Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.
Murakami N; Asami Y; Yoshida H; Takayanagi D; Hirose S; Kuno I; Takahashi K; Matsuda M; Shimada Y; Yamano S; Sunami K; Honda T; Nakahara T; Watanabe T; Okuma K; Kuroda T; Kohno T; Kato T; Shiraishi K; Itami J
Sci Rep; 2021 May; 11(1):10567. PubMed ID: 34012039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
